377 related articles for article (PubMed ID: 31593845)
1. Prognostic significance of blood and lymphatic vessel invasion in pathological stage IA lung adenocarcinoma in the 8th edition of the TNM classification.
Samejima J; Yokose T; Ito H; Nakayama H; Nagashima T; Suzuki M; Hamanaka R; Yamada K; Masuda M
Lung Cancer; 2019 Nov; 137():144-148. PubMed ID: 31593845
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
3. Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma.
Kameda K; Eguchi T; Lu S; Qu Y; Tan KS; Kadota K; Adusumilli PS; Travis WD
J Thorac Oncol; 2018 Dec; 13(12):1919-1929. PubMed ID: 30195703
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma.
Funai K; Sugimura H; Morita T; Shundo Y; Shimizu K; Shiiya N
Ann Surg Oncol; 2011 Oct; 18(10):2968-72. PubMed ID: 21512862
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of the Maximum Standardized Uptake Value on the Prognosis of Clinical Stage IA Lung Adenocarcinoma Based on the 8th Edition TNM Classification.
Shigefuku S; Ito H; Miura J; Kikuchi A; Isaka T; Adachi H; Nakayama H; Ikeda N
Ann Surg Oncol; 2023 Feb; 30(2):830-838. PubMed ID: 36282457
[TBL] [Abstract][Full Text] [Related]
6. Impact of the 8th Edition of the UICC-TNM Classification on Clinical Stage 0-IA Lung Adenocarcinoma: Does the New Classification Predict Postoperative Prognosis More Precisely than the Previous One?
Wang L; Anraku M; Sato M; Nitadori JI; Nagayama K; Kitano K; Nakajima J
Ann Thorac Cardiovasc Surg; 2018 Oct; 24(5):223-229. PubMed ID: 29848840
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Prognosis and Prognostic Indicators of Stage IA Lung Adenocarcinoma.
Yotsukura M; Muraoka Y; Yoshida Y; Nakagawa K; Shiraishi K; Kohno T; Yatabe Y; Watanabe SI
Ann Surg Oncol; 2023 Feb; 30(2):851-858. PubMed ID: 36260144
[TBL] [Abstract][Full Text] [Related]
8. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral lymphatic vessel involvement is an invasive indicator of completely resected pathologic stage I non-small cell lung cancer.
Harada M; Hato T; Horio H
J Thorac Oncol; 2011 Jan; 6(1):48-54. PubMed ID: 21079523
[TBL] [Abstract][Full Text] [Related]
10. Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.
Ito T; Murakawa T; Sato H; Tanabe A; Maekawa M; Yoshida Y; Fukayama M; Nakajima J
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):633-8. PubMed ID: 22740516
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological study of p-T1aN0M0 non-small-cell lung cancer, as defined in the seventh edition of the TNM classification of malignant tumors.
Igai H; Matsuura N; Tarumi S; Chang SS; Misaki N; Go T; Ishikawa S; Yokomise H
Eur J Cardiothorac Surg; 2011 Jun; 39(6):963-7. PubMed ID: 20951601
[TBL] [Abstract][Full Text] [Related]
12. Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer.
Kudo Y; Saji H; Shimada Y; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Lung Cancer; 2013 Aug; 81(2):187-93. PubMed ID: 23664031
[TBL] [Abstract][Full Text] [Related]
13. New T1 classification.
Lin PMF; Hsin MK
Gen Thorac Cardiovasc Surg; 2020 Jul; 68(7):665-671. PubMed ID: 31679135
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma.
Ohno T; Kubouchi Y; Wakahara M; Nosaka K; Sakabe T; Haruki T; Miwa K; Taniguchi Y; Nakamura H; Umekita Y
Anticancer Res; 2018 May; 38(5):3001-3007. PubMed ID: 29715131
[TBL] [Abstract][Full Text] [Related]
15. D2-40-positive lymphatic vessel invasion is not a poor prognostic factor in stage I lung adenocarcinoma.
Shimizu K; Funai K; Sugimura H; Sekihara K; Kawase A; Shiiya N
Pathol Int; 2013 Apr; 63(4):201-5. PubMed ID: 23692420
[TBL] [Abstract][Full Text] [Related]
16. Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancer.
Hashizume S; Nagayasu T; Hayashi T; Hidaka S; Tsuchiya T; Tagawa T; Yamasaki N; Furukawa K; Matsumoto K; Miyazaki T
Lung Cancer; 2009 Sep; 65(3):363-70. PubMed ID: 19157635
[TBL] [Abstract][Full Text] [Related]
17. Effect of epidermal growth factor receptor mutation on early-stage non-small cell lung cancer according to the 8th TNM classification.
Isaka T; Ito H; Nakayama H; Yokose T; Yamada K; Masuda M
Lung Cancer; 2020 Jul; 145():111-118. PubMed ID: 32428800
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
Miyoshi K; Moriyama S; Kunitomo T; Nawa S
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
[TBL] [Abstract][Full Text] [Related]
19. A Population-Based Study of Outcomes in Surgically Resected T3N0 Non-Small Cell Lung Cancer in The Netherlands, Defined Using TNM-7 and TNM-8; Justification of Changes and an Argument to Incorporate Histology in the Staging Algorithm.
Blaauwgeers H; Damhuis R; Lissenberg-Witte BI; de Langen AJ; Senan S; Thunnissen E
J Thorac Oncol; 2019 Mar; 14(3):459-467. PubMed ID: 30408568
[TBL] [Abstract][Full Text] [Related]
20. Verification of the eighth edition of the UICC-TNM classification on surgically resected lung adenocarcinoma: Comparison with previous classification in a local center.
Minato H; Katayanagi K; Kurumaya H; Tanaka N; Fujimori H; Tsunezuka Y; Kobayashi T
Cancer Rep (Hoboken); 2022 Jan; 5(1):e1422. PubMed ID: 34169671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
